Results 31 to 40 of about 689,691 (318)

Impact of network assortativity on epidemic and vaccination behaviour [PDF]

open access: yeschaos, solitons & fractals,140:110143, 2020, 2020
The resurgence of measles is largely attributed to the decline in vaccine adoption and the increase in mobility. Although the vaccine for measles is readily available and highly successful, its current adoption is not adequate to prevent epidemics. Vaccine adoption is directly affected by individual vaccination decisions, and has a complex interplay ...
arxiv   +1 more source

Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors

open access: yesMolecular Therapy: Oncolytics, 2016
To target oncolytic measles viruses (MV) to tumors, we exploit the binding specificity of designed ankyrin repeat proteins (DARPins). These DARPin-MVs have high tumor selectivity while maintaining excellent oncolytic potency.
Jan RH Hanauer   +15 more
doaj   +1 more source

Following in the footsteps of smallpox: can we achieve the global eradication of measles? [PDF]

open access: yes, 2004
BACKGROUND: Although an effective measles vaccine has been available for almost 40 years, in 2000 there were about 30 million measles infections worldwide and 777,000 measles-related deaths.
Morgan, Oliver WC
core   +2 more sources

Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China. [PDF]

open access: yesPLoS ONE, 2017
The safety of measles vaccination is of great interest and importance to public health practice and the general society. We have analyzed the adverse events following immunization (AEFIs) of currently used measles-containing vaccines (including live ...
Fan-Ya Meng   +7 more
doaj   +1 more source

Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models [PDF]

open access: yes, 2009
We evaluated the effectiveness of a measles vaccine campaign in rural Kenya, based on oral-fluid surveys and mixture-modelling analysis. Specimens were collected from 886 children aged 9 months to 14 years pre-campaign and from a comparison sample of 598
A. BETT   +13 more
core   +2 more sources

A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions. [PDF]

open access: yes, 2014
Observational studies and trials from low-income countries indicate that measles vaccine has beneficial nonspecific effects, protecting against non-measles-related mortality.
Aaby   +54 more
core   +2 more sources

A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2020
Significance The COVID-19 pandemic has already caused over 1 million deaths. Therefore, effective vaccine concepts are urgently needed. In search of such a concept, we have analyzed a measles virus-based vaccine candidate targeting SARS-CoV-2. Using this
Cindy Hörner   +10 more
semanticscholar   +1 more source

Measles Aerosol Vaccine Project [PDF]

open access: yes, 2010
Aerosol delivery of measles vaccine to the respiratory mucosa, mimicking the natural route of transmission for measles virus, is the most promising non-injectable method of measles vaccination studied so far.
Aguado, Teresa   +4 more
core   +1 more source

EXPERIMENTAL MEASLES VACCINES: A RESEARCH TOOL IN VACCINATION EVENTS

open access: yesМедицинская иммунология, 2014
. The review article considers different variants of measles vaccine that may be classified into two groups, i.e., vaccines that do not contain viable measles virus, and attenuated measles vaccines which could be employed in unusual manner.The first ...
V. A. Liashenko
doaj   +1 more source

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Measles is a vaccine-preventable viral disease whose vaccination coverage remains low in Zambia, where the target group for vaccination is children aged 9 to 18 months.
Kalonde Malama   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy